Real‑life cost and cost‑effectiveness for tiotropium 18 μg od monotherapy in moderate and severe COPD patients: a 48‑month survey. FE [Internet]. 2014 Jun. 30 [cited 2025 Oct. 29];15(2):39-44. Available from: https://journals.seedstm.com/index.php/FE/article/view/924